Harmane

CAT:
804-HY-101392-01
Size:
50 mg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Harmane - image 1

Harmane

  • Description :

    Harmane is a benzodiazepine receptor inhibitor (IC50=7 μM), with IC50 values for mACh, Opioid Receptor, MAO-A/B, and α2-adrenergic receptor of 24 μM, 2.8 μM, 0.5 μM, 5 μM, and 18 μM, respectively. Harmane inhibits the I1 imidazoline receptor (IC50 = 30 nM) to reduce blood pressure and has antidepressant, anti-anxiety, anticonvulsant, and analgesic effects. Harmane inhibits dopamine biosynthesis by decreasing tyrosine hydroxylase (TH) activity and enhancing L-DOPA-induced cytotoxicity in PC12 cells. Additionally, Harmane can increase the mutagenic effect induced by 2-acetylaminofluorene (AAF) [1][2][3][4][5][6].
  • UNSPSC :

    12352005
  • Hazard Statement :

    H302, H315, H319, H335
  • Target :

    Adrenergic Receptor; GABA Receptor; Imidazoline Receptor; Monoamine Oxidase; nAChR; Opioid Receptor
  • Type :

    Natural Products
  • Related Pathways :

    GPCR/G Protein; Membrane Transporter/Ion Channel; Neuronal Signaling
  • Applications :

    Cancer-programmed cell death
  • Field of Research :

    Inflammation/Immunology; Neurological Disease
  • Assay Protocol :

    https://www.medchemexpress.com/harmane.html
  • Purity :

    99.91
  • Solubility :

    DMSO : 100 mg/mL (ultrasonic) |H2O : < 0.1 mg/mL (ultrasonic; warming; heat to 60°C)
  • Smiles :

    CC1=NC=CC2=C1NC3=C2C=CC=C3
  • Molecular Formula :

    C12H10N2
  • Molecular Weight :

    182.23
  • Precautions :

    H302, H315, H319, H335
  • References & Citations :

    [1]Musgrave IF, et, al. Harmane produces hypotension following microinjection into the RVLM: possible role of I (1) -imidazoline receptors. Br J Pharmacol. 2000 Mar;129 (6) :1057-9.|[2]Glover V, et, al. β-Carbolines as selective monoamine oxidase inhibitors:In vivo implications|[3]Umezawa K, et, al. Comutagenic effect of norharman and harman with 2-acetylaminofluorene derivatives. Proc Natl Acad Sci U S A. 1978 Feb;75 (2) :928-30.|[4]W E Müller, et al. On the neuropharmacology of harmane and other beta-carbolines. Pharmacol Biochem Behav. 1981 May;14 (5) :693-9.|[5]E D Louis, et al. Harmane induces anxiolysis and antidepressant-like effects in rats. Ann N Y Acad Sci. 2005 Aug 9;65 (3) :391-6.|[6]Yoo Jung Yang, et al. Effects of harman and norharman on dopamine biosynthesis and L-DOPA-induced cytotoxicity in PC12 cells. Eur J Pharmacol. 2008 Jun 10;587 (1-3) :57-64.
  • Shipping Conditions :

    Room Temperature
  • Storage Conditions :

    -20°C, 3 years; 4°C, 2 years (Powder)
  • Scientific Category :

    Natural Products
  • Clinical Information :

    No Development Reported
  • Isoform :

    MAO-A; MAO-B; α adrenergic receptor
  • CAS Number :

    [486-84-0]

Featured Selection

Popular Products

Discover our most sought-after biotechnology products, trusted by researchers worldwide